RayanaAI
Account
SNY
HOLD / NEUTRALMeanRev
Composite
56.40
Technical
56.20
Fundamental
56.50
Rank
—
Price
44.34
Hurst
0.04
As of
Nov 2, 2026
Daily
Sanofi
HealthcareDrug Manufacturers - General

Sanofi is a pharmaceutical company that researches, develops, manufactures, and markets drugs and vaccines across multiple therapeutic areas including immunology, inflammation, rare diseases, neurology, and oncology. Its vaccine portfolio includes formulations for polio, pertussis, and influenza, as well as combination vaccines protecting against hepatitis A, typhoid, yellow fever, and rabies. The company maintains numerous partnerships with biotechnology firms to advance treatments in areas such as oncology, neurological disorders, inflammatory diseases, and cell therapy, while also collaborating on artificial intelligence platforms and genome editing technologies for drug development.

Market cap
$107.2B
P/E (trailing)
22.26
P/E (forward)
8.51
PEG ratio
31.46
Dividend yield
545.00%
Beta
0.27
52w range
39.07 – 52.68
Return on equity
+5.72%
Profit margin
+8.19%
Revenue growth
+15.70%
Earnings growth
+9.40%
Price history

1Y: 44.74 (-5.7%) · range 39.12–49.59

Cycle position
40/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 38 · WEAK SETUP · exit proximity 0

Conviction
47/ 100 · maturity 14%
VScore.0919
Buildup.3058
EMA entry setup.3838
Fundamentals.2357
Volume profile
POC
42.80
Price vs POC
+4.5%
Overhead supply
11%
Runway
open sky

Value area 41.60–45.12 · 11% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.900
Nov 2, 2026
Forward returns

Not yet labeled — the study prices these as positions mature.